Harvard Bioscience said that once fully implemented, the move will provide about $4 million in annual cost savings.
Streamlining production footprint and improving manufacturing efficiency through phased closure of Holliston, MA plant ...
The company is guiding to a revenue range of $22.5 million to $24.5 million for Q4 2025, with Frost noting, "The lower end of the range reflects the potential risk of a prolonged U.S. government ...
Holliston biotechnology firm Harvard Bioscience continued its fourth quarter momentum with revenue up 14% in the first quarter of 2021 when compared to the first quarter of 2020. Holliston ...
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, ...
Hosted on MSN
Harvard Bioscience outlines $19M–$21M Q3 revenue target as debt refinancing advances and product adoption accelerates
John Duke, President and CEO, shared his initial observations as the new leader, stating he is "encouraged" by the company's operating team, innovation pipeline, and culture. He emphasized three ...
Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.025. Operator: Good day, and welcome to the Second Quarter 2025 Harvard Bioscience Earnings ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
The MarketWatch News Department was not involved in the creation of this content. HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or ...
Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial Flexibility BroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board ...
Jim Green will retire from his roles as chairman, president, and CEO of Harvard Bioscience on July 28. Harvard Bioscience falls out of Nasdaq compliance after board member resignation Harvard ...
Operator: Good day, and welcome to the Third Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results